201 related articles for article (PubMed ID: 36479439)
1. RNA G-quadruplex forming regions from SARS-2, SARS-1 and MERS coronoviruses.
Kabbara A; Vialet B; Marquevielle J; Bonnafous P; Mackereth CD; Amrane S
Front Chem; 2022; 10():1014663. PubMed ID: 36479439
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression.
Razzaq M; Han JH; Ravichandran S; Kim J; Bae JY; Park MS; Kannappan S; Chung WC; Ahn JH; Song MJ; Kim KK
Arch Pharm Res; 2023 Jul; 46(7):598-615. PubMed ID: 37563335
[TBL] [Abstract][Full Text] [Related]
3. CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands.
Bezzi G; Piga EJ; Binolfi A; Armas P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807682
[TBL] [Abstract][Full Text] [Related]
4. The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19.
Panera N; Tozzi AE; Alisi A
Drugs; 2020 Jul; 80(10):941-946. PubMed ID: 32451923
[TBL] [Abstract][Full Text] [Related]
5. Targeting RNA G-Quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19?
Zhao C; Qin G; Niu J; Wang Z; Wang C; Ren J; Qu X
Angew Chem Int Ed Engl; 2021 Jan; 60(1):432-438. PubMed ID: 32939952
[TBL] [Abstract][Full Text] [Related]
6. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review.
Zhai LY; Su AM; Liu JF; Zhao JJ; Xi XG; Hou XM
Int J Biol Macromol; 2022 Nov; 221():1476-1490. PubMed ID: 36130641
[TBL] [Abstract][Full Text] [Related]
8. Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication.
Oudshoorn D; Rijs K; Limpens RWAL; Groen K; Koster AJ; Snijder EJ; Kikkert M; Bárcena M
mBio; 2017 Nov; 8(6):. PubMed ID: 29162711
[TBL] [Abstract][Full Text] [Related]
9. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
10. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
[TBL] [Abstract][Full Text] [Related]
11. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
[TBL] [Abstract][Full Text] [Related]
12. G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters.
Roy SS; Sharma S; Rizvi ZA; Sinha D; Gupta D; Rophina M; Sehgal P; Sadhu S; Tripathy MR; Samal S; Maiti S; Scaria V; Sivasubbu S; Awasthi A; Harshan KH; Jain S; Chowdhury S
Front Mol Biosci; 2023; 10():1133123. PubMed ID: 37006620
[TBL] [Abstract][Full Text] [Related]
13. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
14. G-Quadruplex Targeting in the Fight against Viruses: An Update.
Ruggiero E; Zanin I; Terreri M; Richter SN
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681641
[TBL] [Abstract][Full Text] [Related]
15. RNA G-quadruplex formed in SARS-CoV-2 used for COVID-19 treatment in animal models.
Qin G; Zhao C; Liu Y; Zhang C; Yang G; Yang J; Wang Z; Wang C; Tu C; Guo Z; Ren J; Qu X
Cell Discov; 2022 Sep; 8(1):86. PubMed ID: 36068208
[TBL] [Abstract][Full Text] [Related]
16. Discovery of G-quadruplex-forming sequences in SARS-CoV-2.
Ji D; Juhas M; Tsang CM; Kwok CK; Li Y; Zhang Y
Brief Bioinform; 2021 Mar; 22(2):1150-1160. PubMed ID: 32484220
[TBL] [Abstract][Full Text] [Related]
17. The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections.
Sajini AA; Alkayyal AA; Mubaraki FA
J Epidemiol Glob Health; 2021 Jun; 11(2):155-159. PubMed ID: 33605109
[TBL] [Abstract][Full Text] [Related]
18. Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.
Lokugamage KG; Narayanan K; Nakagawa K; Terasaki K; Ramirez SI; Tseng CT; Makino S
J Virol; 2015 Nov; 89(21):10970-81. PubMed ID: 26311885
[TBL] [Abstract][Full Text] [Related]
19. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
[No Abstract] [Full Text] [Related]
20. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
